BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 16, 2024
See today's BioWorld MedTech
Home
» Dinaqor describes platform for perfusion of the kidney
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Patents
Dinaqor describes platform for perfusion of the kidney
March 26, 2024
By
Simon Kerton
Schlieren, Switzerland-headquartered Dinaqor AG reported seeking further protection for a technique for loco-regional perfusion (LRP) of a kidney and specifically claims the genes it may be used to deliver.
BioWorld MedTech